Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001336 · ClinicalTrials.gov registry record
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,000
- Enrollment target
NCT00001336: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001336 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001336 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Peripheral blood mononuclear cells (PBMC) will be collected from patients who have leukemia or lymphoma or other medical conditions involving altered lymphohematopoietic stem cell or immunological function. These PBMC will be assessed for cellular markers by flow cytometry and will be studied for in vitro T helper, effector and suppressor cell functions, to determine whether cell mediated immunity is involved in the condition, or indicative of therapeutic efficacy or is predictive for outcome. Peripheral blood stem cells (PBSC) from untreated donors and from cytokine treated donors will be assessed for cellular markers and in vitro growth characteristics that might be useful for identifying normal stem cell populations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 1993-04 |
| Est. Completion | 2003-02 |
What the finished NCT00001336 record still lists
NCT00001336 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001336 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001336 about?
NCT00001336 is a clinical study titled "In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients". Peripheral blood mononuclear cells (PBMC) will be collected from patients who have leukemia or lymphoma or other medical conditions involving altered lymphohematopoietic stem cell or immunological function. These PBMC will be assessed for cellular markers by flow cytometry and will be studied for in...
What is the current status of trial NCT00001336?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 1993-04. Estimated completion is 2003-02.
Who is sponsoring clinical trial NCT00001336?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia